Asset
CAPROMAB PENDETIDE
Aytu BioPharma Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (0)
No records yet.
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| BLA 103608 | BLA | Aytu BioScience, Inc. |
Marketed products (1)
- PROSTASCINT